Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide brain natriuretic peptide and plasma norepinephrine

被引:24
作者
Bertinchant, JP
Combes, N
Polge, A
Fabbro-Peray, P
Raczka, F
Beck, L
Cade, S
Ledermann, B
机构
[1] Univ Nimes Hosp, Dept Cardiol, F-30029 Nimes 9, France
[2] Univ Hosp, Dept Cardiol, F-34295 Montpellier, France
[3] Univ Nimes Hosp, Dept Biochem, F-30006 Nimes, France
[4] Univ Nimes Hosp, Dept Biostat & Epidemiol, F-30006 Nimes, France
关键词
cardiac troponin T; ANP; BNP; norepinephrine; heart failure;
D O I
10.1016/j.cccn.2004.09.009
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The prognostic value of cardiac troponin T (cTn-T) in a mixture of patients with both acute and chronic congestive heart failure (CHF), simultaneously assessed and compared with neurohormonal factors, has not yet been thoroughly evaluated. Thus, we focused on the prognostic value of cTn-T in comparison with atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and plasma norepinephrine (PNE) in this population. Methods: Prognostic correlates of elevation of cTn-T, ANP, BNP, PNE were analyzed in 63 acute and chronic CHF patients followed up to record worsening CHF and cardiac death. Results: cTn-T ( greater than or equal to0.03 mug/L) was found in 17.4% (11 of 63) of patients. cTn-T correlated with ANP, BNP, PNE. Acute Cl-IF patients were more positive for cTn-T and BNP. In our cohort, neither cTn-T (greater than or equal to 0.03 mug/L) nor PNE were associated with increased mortality and worsening HF in CHF patients. After adjustment, BNP was the only independent predictor of cardiac events (RR, 3.23; p=0.01). Conclusions: BNP emerged as the only independent predictor of cardiac events in a mixture of patients with both acute and chronic CHF, suggesting that it is the analyte that best reflects long-term prognosis in a diverse population enrolled to mirror the "real world situation. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 34 条
[1]   CARDIAC TROPONIN-I - A MARKER WITH HIGH SPECIFICITY FOR CARDIAC INJURY [J].
ADAMS, JE ;
BODOR, GS ;
DAVILAROMAN, VG ;
DELMEZ, JA ;
APPLE, FS ;
LADENSON, JH ;
JAFFE, AS .
CIRCULATION, 1993, 88 (01) :101-106
[2]   European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials [J].
Apple, FS ;
Wu, AHB ;
Jaffe, AS .
AMERICAN HEART JOURNAL, 2002, 144 (06) :981-986
[3]   STRUCTURAL BASIS OF END-STAGE FAILURE IN ISCHEMIC CARDIOMYOPATHY IN HUMANS [J].
BELTRAMI, CA ;
FINATO, N ;
ROCCO, M ;
FERUGLIO, GA ;
PURICELLI, C ;
CIGOLA, E ;
QUAINI, F ;
SONNENBLICK, EH ;
OLIVETTI, G ;
ANVERSA, P .
CIRCULATION, 1994, 89 (01) :151-163
[4]   Monitoring of cardiac troponin I in patients with acute heart failure [J].
Chen, YN ;
Wei, JR ;
Zeng, LJ ;
Wu, MY .
ANNALS OF CLINICAL BIOCHEMISTRY, 1999, 36 :433-437
[5]   Risk stratification in chronic heart failure [J].
Cowburn, PJ ;
Cleland, JGF ;
Coats, AJS ;
Komajda, M .
EUROPEAN HEART JOURNAL, 1998, 19 (05) :696-710
[6]   Cardiac troponins in congestive heart failure [J].
Del Carlo, CH ;
O'Connor, CM .
AMERICAN HEART JOURNAL, 1999, 138 (04) :646-653
[7]   Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure [J].
Del Carlo, CH ;
Pereira-Barretto, AC ;
Cassaro-Strunz, C ;
Latorre, MDDO ;
Ramires, JAF .
JOURNAL OF CARDIAC FAILURE, 2004, 10 (01) :43-48
[8]  
Feng J, 2001, CIRCULATION, V103, P2035
[9]  
Hallermayer K, 1999, SCAND J CLIN LAB INV, V59, P128
[10]   Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure [J].
Horwich, TB ;
Patel, J ;
MacLellan, WR ;
Fonarow, GC .
CIRCULATION, 2003, 108 (07) :833-838